Anat
Anat Achiron, Tel-Aviv IL
Patent application number | Description | Published |
---|---|---|
20100074864 | METHODS AND KITS FOR PREDICTING PROGNOSIS OF MULTIPLE SCLEROSIS - Provided are methods and kits for predicting the prognosis of a subject diagnosed with multiple sclerosis by determining the expression level of polynucleotides which are differentially expressed between subjects diagnosed with multiple sclerosis and having good or poor clinical outcome. Also provided are methods and kits for selecting a treatment regimen of a subject diagnosed with multiple sclerosis. | 03-25-2010 |
20100112568 | METHODS AND KITS FOR DIAGNOSIS OF MULTIPLE SCLEROSIS IN PROBABLE MULTIPLE SCLEROSIS SUBJECTS - Provided are methods and kits for determining the probability of a subject diagnosed with probable multiple sclerosis to develop definite diagnosis of multiple sclerosis by determining the expression level of polynucleotides which are differentially expressed between subjects diagnosed with probable multiple sclerosis and which further develop definite multiple sclerosis and unaffected subjects. Also provided are methods and kits for selecting a treatment regimen of a subject diagnosed with probable multiple sclerosis. | 05-06-2010 |
20100150868 | Methods of Individually Optimizing Treatment for an Inflammation Associated Disease - A method of individually optimizing a treatment for an inflammation associated disease is provided. The method comprising contacting each of identical white blood cell samples of a subject in need thereof with a different pharmaceutical agent of a plurality of pharmaceutical agents for the inflammation associated disease, so as to allow elicitation of an anti-inflammatory activity in the white blood cell samples; assaying the anti-inflammatory activity in the white blood cell samples; and identifying a pharmaceutical agent of the plurality of pharmaceutical agents eliciting a strongest anti-inflammatory activity, the pharmaceutical agent being the individually optimized treatment for the inflammation associated disease, wherein when the inflammation associated disease is multiple sclerosis the white blood cell samples are inflamed white blood cell samples. Methods of treating an inflammation associated disease are also described. | 06-17-2010 |
20120020954 | METHODS OF PREDICTING CLINICAL COURSE AND TREATING MULTIPLE SCLEROSIS - Provided are methods and kits for classifying a subject as being more likely to have benign multiple sclerosis (BMS) or as being more likely to have typical relapsing remitting multiple sclerosis (RRMS). Classification of multiple sclerosis disease course is performed by comparing a level of expression of at least one gene involved in the RNA polymerase I pathway in a cell of the subject to a reference expression data of said at least one gene obtained from a cell of at least one subject pre-diagnosed as having BMS and/or from a cell of at least one subject pre-diagnosed as having typical RRMS, thereby classifying the subject as being more likely to have BMS or as being more likely to have typical RRMS. Also provided are methods of diagnosing and treating multiple sclerosis and methods of monitoring treatment efficiency. | 01-26-2012 |
20140086839 | QUINOLONE ANALOGS FOR TREATING AUTOIMMUNE DISEASES - Provided are methods of treating autoimmune diseases by administering to the subject a therapeutically effective amount of a quinolone compound such as 2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide (CX-5461). Also provided are methods of monitoring efficiency of treatment of the quinolone compound by determining the expression level of at least one gene of the RNA polymerase I pathway. | 03-27-2014 |
20150284410 | RNA POLYMERASE I INHIBITORS AND USES THEREOF - Provided are novel compounds which are capable of inhibiting an activity of RNA polymerase I, and uses thereof in treating diseases or disorders modulated by RNA polymerase I, preferably autoimmune diseases such as multiple sclerosis and proliferative diseases. | 10-08-2015 |
20150315646 | METHODS OF PREDICTING CLINICAL COURSE AND TREATING MULTIPLE SCLEROSIS - Provided are methods and kits for classifying a subject as being more likely to have benign multiple sclerosis (BMS) or as being more likely to have typical relapsing remitting multiple sclerosis (RRMS). Classification of multiple sclerosis disease course is performed by comparing a level of expression of at least one gene involved in the RNA polymerase I pathway in a cell of the subject to a reference expression data of said at least one gene obtained from a cell of at least one subject pre-diagnosed as having BMS and/or from a cell of at least one subject pre-diagnosed as having typical RRMS, thereby classifying the subject as being more likely to have BMS or as being more likely to have typical RRMS. Also provided are methods of diagnosing and treating multiple sclerosis and methods of monitoring treatment efficiency. | 11-05-2015 |
20160032393 | METHODS AND KITS FOR PREDICTING PROGNOSIS OF MULTIPLE SCLEROSIS - Provided are methods and kits for predicting the prognosis of a subject diagnosed with multiple sclerosis by determining the expression level of polynucleotides which are differentially expressed between subjects diagnosed with multiple sclerosis and having good or poor clinical outcome. Also provided are methods and kits for selecting a treatment regimen of a subject diagnosed with multiple sclerosis. | 02-04-2016 |
Anat Afriat Herskovits, Kfar-Saba IL
Patent application number | Description | Published |
---|---|---|
20150368654 | MODIFIED LISTERIA BACTERIA AND USES THEREOF | 12-24-2015 |
Anat Arzi, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20120272958 | DEVICE AND METHOD FOR CONTROLLING RESPIRATION DURING SLEEP - A device for controlling respiration during sleep, the device comprising: | 11-01-2012 |
Anat Bar-Anan, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20100217890 | USING SERVER TYPE TO OBTAIN NETWORK ADDRESS - Aspects of the subject matter described herein relate to using server type to obtain a network address. In aspects, a gateway that sits between a single network protocol client and a server receives a request from the client for a network address of the server. The gateway issues multiple name resolution requests and waits for a first response. Depending on various factors, the gateway determines whether or not to wait for additional responses before responding to the client. If needed, the gateway may obtain an address of a translating device to assist the client in communicating with the server. | 08-26-2010 |
20110283103 | ONE TIME PASSWORDS WITH IPSEC AND IKE VERSION 1 AUTHENTICATION - A system adapted to condition access to a network over an IPsec session to clients providing a proper one-time-password, even though the network access control uses IKEv1, which does not support one-time-passwords. An authentication service receives from a client an access request including the one-time-password, and provides the one-time-password to a service that checks the password. The one-time-password service returns a cookie when the password is successfully validated and the client is properly authenticated. The cookie is passed on to the client computer, which uses the cookie as part of a request for a certificate. A certificate authority generates a certificate if a request for a certificate is received from an authenticated client, which in turn may be used to form the IPsec session for access to the network. | 11-17-2011 |
20120210123 | ONE-TIME PASSWORD CERTIFICATE RENEWAL - Embodiments are directed to providing a certificate extension to an authentication certificate, to validating an authentication certificate request and to implementing authentication certificates that include certificate extensions. In an embodiment, a computer system accesses an authentication certificate request that is to be sent to a validation server for validation and to a certificate authority for issuance of an authentication certificate. The computer system appends an extension to the authentication certificate request. The extension includes origination information about the authentication certificate. The computer system then sends the authentication certificate request with the appended extension to the validation server for validation. | 08-16-2012 |
Anat Bashan, Nes Ziona IL
Patent application number | Description | Published |
---|---|---|
20090081697 | Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, and methods of rationally designing or identifying antibiotics using structure coordinate data derived from such crystals - Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, coordinates defining the 3D atomic structure thereof and methods of utilizing such coordinates for rational design or identification of antibiotics or large ribosomal subunits having desired characteristics are disclosed. | 03-26-2009 |
Anat Bashan, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20120316106 | SYNERGISTIC ANTIBIOTIC COMBINATIONS AND DERIVATIVES - Improved antibiotic analogs, and synergistic combinations of antibiotics designed based on structural crystallographic analysis, are provided as well as pharmaceutical compositions that include these improved analogs and synergistic combinations, along with methods for their production and use. The synergistic combinations target neighboring sites in the ribosome demonstrating the importance of the corresponding ribosomal sites for development of clinically-relevant synergistic antibiotics. | 12-13-2012 |
Anat Ben-Shlomo, Beverly Hills, CA US
Patent application number | Description | Published |
---|---|---|
20080253641 | Method for Drug Screening and Characterization by Calcium Flux - The instrumentation and methods described herein are based on imaging and measuring single cell dose response by fluorescent ion imaging that records live cell responses to drug doses with no apparent damage to the cells or toxic side effects. Dose response curves and other pharmacological parameters can be computed by imaging and measuring oscillation changes for each dose and each cell. Large variability of cellular responses under the same experimental conditions indicates that pharmacological benchmarks are determined by statistical distribution of cells and cellular physiology. The instrumentation and methods described herein provide a means of measuring statistical variability of cell populations for improved screening and development methods for drugs. | 10-16-2008 |
Anat Berkman, Haifa IL
Patent application number | Description | Published |
---|---|---|
20150135324 | HYPERLINK DATA PRESENTATION - A method of presenting hyperlink data. The method comprises identifying when a web browser running on a web browser client retrieves, in response to a web document data request submitted to a target server, a first web document data for displaying a first web document containing a hyperlink having a label for display and a target destination defining an address of a second web document, evaluating a risk from content of the second web document, generating by the web browser to a reference evaluation indication of the risk, and processing the web document data and the reference evaluation indication by the web browser for generating a presentation on the client terminal which combines the first web document data and the reference evaluation indication such that when the reference evaluation indication is presented when the label is presented by the web browser. | 05-14-2015 |
Anat Biegon, Port Jefferson, NY US
Patent application number | Description | Published |
---|---|---|
20100209344 | Radio-methyl Vorozole and Methods for Making and Using the Same - Radiotracer vorozole compounds for in vivo and in vitro assaying, studying and imaging cytochrome P450 aromatase enzymes in humans, animals, and tissues and methods for making and using the same are provided. [N-radio-methyl] vorozole substantially separated from an N-3 radio-methyl isomer of vorozole is provided. Separation is accomplished through use of chromatography resins providing multiple mechanisms of selectivity. | 08-19-2010 |
20130225831 | Radio-methyl Vorozole and Methods for Making and Using the Same - Radiotracer vorozole compounds for in vivo and in vitro assaying, studying and imaging cytochrome P450 aromatase enzymes in humans, animals, and tissues and methods for making and using the same are provided. [N-radio-methyl] vorozole substantially separated from an N-3 radio-methyl isomer of vorozole is provided. Separation is accomplished through use of chromatography resins providing multiple mechanisms of selectivity. | 08-29-2013 |
Anat Bordoley, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20160083083 | VORTEX GENERATORS RESPONSIVE TO AMBIENT CONDITIONS - A deployable vortex generator attached to a lifting surface includes a vane moveable relative to the lifting surface. The vane moves from a deployed position to a retracted position in response to a change in ambient conditions. In the deployed position, the vane acts on the air flow to create vortices. In the retracted position, the vane is closely aligned with the free stream velocity. | 03-24-2016 |
Anat Brembler-Barr, Ramat Hasharon IL
Patent application number | Description | Published |
---|---|---|
20130254197 | METHOD AND SYSTEM FOR DECOMPRESSION-FREE INSPECTION OF SHARED DICTIONARY COMPRESSED TRAFFIC OVER HTTP - A system and a method for decompression-free inspection of compressed data are provided herein. The method includes the following stages: obtaining a dictionary file comprising a string of symbols, each associated with a respective index; obtaining at least one delta file associated with said dictionary file, wherein said delta file comprises a sequence of instructions that include at least one copy instruction pointing to an index within said dictionary and a length of a copy substring to be copied; scanning said dictionary using a pattern matching algorithm associated with a plurality of patterns and implemented as a Deterministic Finite Automaton (DFA), to yield DFA execution data; scanning said at least one delta file, using said pattern matching algorithm, wherein said DFA execution data is used to skip at least part of the scanning of the copy substrings for at least one of the copy instructions. | 09-26-2013 |
Anat Bremler-Barr, Ramat Hasharon IL
Patent application number | Description | Published |
---|---|---|
20100250737 | DETECTING AND CONTROLLING PEER-TO-PEER TRAFFIC - A method for communication management includes detecting addresses of peer nodes ( | 09-30-2010 |
20110167030 | STATE MACHINE COMPRESSION FOR SCALABLE PATTERN MATCHING - A method for processing data includes encoding a finite automaton, which includes states and transitions between the states that express a plurality of predefined patterns, by grouping the states of the automaton into sets according to a common property shared by the states in each set, and assigning codes to the states according to the grouping. The codes are stored in an electronic memory, along with rules that are associated with the patterns. The automaton is traversed in order to identify one or more of the patterns in an input sequence of data elements by iteratively reading out the codes from the memory responsively to the data elements and to the codes that have been previously read out. Upon identifying a given pattern in the input sequence, an associated action is performed. | 07-07-2011 |
20110185077 | MULTI-PATTERN MATCHING IN COMPRESSED COMMUNICATION TRAFFIC - A method for processing data includes accepting a specification of a plurality of patterns, each pattern defining a respective uncompressed sequence of symbols. Multi-pattern matching is applied to an incoming stream of compressed communication traffic containing compression metadata so as to identify the patterns occurring in the stream while using the compression metadata to skip over parts of the stream. | 07-28-2011 |
20120117431 | EFFICIENT DETECTION OF ERRORS IN ASSOCIATIVE MEMORY - A method for error detection includes storing in an associative memory ( | 05-10-2012 |
20120243551 | Efficient Processing of Compressed Communication Traffic - A method for processing communication traffic includes receiving an incoming stream of compressed data conveyed by a sequence of data packets, each containing a respective portion of the compressed data. The respective portion of the compressed data contained in the first packet is stored in a buffer, having a predefined buffer size. Upon receiving a subsequent packet, at least a part of the compressed data stored in the buffer and the respective portion of the compressed data contained in the subsequent packet are decompressed, thereby providing decompressed data. A most recent part of the decompressed data that is within the buffer size is recompressed and stored in the buffer. | 09-27-2012 |
Anat Bruchim, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20100151020 | DRUG DELIVERY SYSTEM FOR ZERO ORDER, ZERO ORDER BIPHASIC, ASCENDING OR DESCENDING DRUG DELIVERY OF METHYLPHENIDATE - The invention is directed to a drug delivery device for controlled release of a drug, such as methylphenidate hydrochloride. The drug deliver device has a drug core, having a plug embedded therein, and at least a first coating that at least partially surrounds the core. The plug may be hollow or solid, and swells upon absorption of water, bursting through the first coating. The drag delivery device enables zero-order drug release profiles as well as more complicated release profiles to be obtained. | 06-17-2010 |
Anat Bzoza, Tel-Aviv IL
Patent application number | Description | Published |
---|---|---|
20100328422 | Method and System for Composing Video Images from a Plurality of Endpoints - The present application discloses a method and apparatus for a multipoint video conferencing system that can offer a wide variety of layouts and the ability to support a large number of conferees. A received stream of NALs from a plurality of endpoints can be processed by an exemplary NAL Processor Module (NPM) and be arranged into a stream of NALs that are referred to in this disclosure as organized NALs (ONALs). Two or more streams of compressed video organized into ONALs can be received by an exemplary NAL Editor Module (NEM), wherein each stream was created from a video image that was generated at an endpoint participating in the conference. An exemplary NEM can comprise a compressed composed frame memory (CCFM) module. Each CCFM can be divided into segments according to the layout of the continuous presence (CP) image that is to be displayed by one or more receiving endpoints. | 12-30-2010 |
20120206563 | Method and System for Composing Video Images from a Plurality of Endpoints - The present application discloses a method and apparatus for a multipoint video conferencing system that can offer a wide variety of layouts and the ability to support a large number of conferees. A received stream of NALs from a plurality of endpoints can be processed by an exemplary NAL Processor Module (NPM) and be arranged into a stream of NALs that are referred to in this disclosure as organized NALs (ONALs). Two or more streams of compressed video organized into ONALs can be received by an exemplary NAL Editor Module (NEM), wherein each stream was created from a video image that was generated at an endpoint participating in the conference. An exemplary NEM can comprise a compressed composed frame memory (CCFM) module. Each CCFM can be divided into segments according to the layout of the continuous presence (CP) image that is to be displayed by one or more receiving endpoints. | 08-16-2012 |
Anat Cohen-Dayag, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20090202991 | NOVEL DIAGNOSTIC MARKERS, ESPECIALLY FOR IN VIVO IMAGING AND ASSAYS AND METHODS OF USE THEREOF - Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry. | 08-13-2009 |
20100189652 | NOVEL DIAGNOSTIC MARKERS, ESPECIALLY FOR IN VIVO IMAGING, AND ASSAYS AND METHODS OF USE THEREOF - Novel splice variants as diagnostic markers, preferably membrane-bound. The novel variants according to the present invention may optionally be used for diagnosis of Marker-detectable disease as described herein, optionally through immunohistochemistry. | 07-29-2010 |
20110003708 | BIOMARKERS FOR THE PREDICTION OF RENAL INJURY - The present invention relates to means and methods for predicting the onset of renal injury based on measuring the expression of polynucleotides and proteins, particularly on measuring the expression of sets of novel as well as known polynucleotides and proteins, and to kits utilizing same. | 01-06-2011 |
20110052501 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KIAA0746, CD20 or CD55 antigens, which are differentially expressed in cancer and in specific blood cells, and diagnostic and therapeutic usages. This invention further relates to the discovery of extracellular domains of KIAA0746 and its variants, CD20 and its variants, CD55 and its variants, which are suitable targets for immunotherapy, cancer therapy, treatment of inflammatory, allergic and autoimmune disorders, and drug development. | 03-03-2011 |
20110311450 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KRTCAP3, FAM26F, MGC52498, FAM70A or TMEM154 antigens, which are differentially expressed in cancer, and diagnostic and therapeutic usages. This invention further relates to extracellular domains of KRTCAP3, FAM26F, MGC52498, FAM70A and TMEM154 proteins and variants, and therapeutic usages thereof. | 12-22-2011 |
20120134997 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants which are suitable targets for immunotherapy, cancer therapy, and drug development. | 05-31-2012 |
20130315819 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KIAA0746, CD20 or CD55 antigens, which are differentially expressed in cancer and in specific blood cells, and diagnostic and therapeutic usages. This invention further relates to the discovery of extracellular domains of KIAA0746 and its variants, CD20 and its variants, CD55 and its variants, which are suitable targets for immunotherapy, cancer therapy, treatment of inflammatory, allergic and autoimmune disorders, and drug development. | 11-28-2013 |
20140220011 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, ClORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and ClORF32 and its variants which are suitable targets for immunotherapy, cancer therapy, and drug development. | 08-07-2014 |
20140255389 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants which are suitable targets for immunotherapy, cancer therapy, and drug development. | 09-11-2014 |
20140255411 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants a which are suitable targets for immunotherapy, cancer therapy, and drug development. | 09-11-2014 |
20140363446 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants awhich are suitable targets for immunotherapy, cancer therapy, and drug development. | 12-11-2014 |
20160068606 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KRTCAP3, FAM26F, MGC52498, FAM70A or TMEM154 antigens, which are differentially expressed in cancer, and diagnostic and therapeutic usages. This invention further relates to extracellular domains of KRTCAP3, FAM26F, MGC52498, FAM70A and TMEM154 proteins and variants, and therapeutic usages thereof. | 03-10-2016 |
Anat Elmann, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20150320700 | Geranium oil and constituents thereof for treatment of neurodegenerative diseases - The invention relates to the use of effective amount of | 11-12-2015 |
20150359832 | Anti-neuroinflammatory and antioxidative effects of Pi infusion - implications for neurodegenerative diseases - This invention relates to the use | 12-17-2015 |
Anat Fischer, Haifa IL
Patent application number | Description | Published |
---|---|---|
20110022174 | MODELING MICRO-SCAFFOLD-BASED IMPLANTS FOR BONE TISSUE ENGINEERING - A new conceptual biomedical method is presented for designing scaffold-based bone implants and using these implants in treating deteriorated bones. These implants have micro-architectural bone structures that are capable of mimicking the stochastic micro-structure as in natural bone bio-mineral structures. Moreover, they can be adapted as specific tailor-made compatible bone-repair mediator implants to be used as effective substitutes for natural damaged bone fracture structures. | 01-27-2011 |
Anat Fradin, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20110161518 | ASYNCHRONOUS INVOCATION MECHANISM IN SESSION INITIATION PROTOCOL (SIP) SERVER CLUSTERS - Providing SIP application server interoperability, including detecting at a first SIP application server an event necessitating that work be performed in relation to a SIP application session that is managed by a second SIP application server, creating a SIP message object carrying a set of instructions representing the work, and sending the SIP message object for delivery to the second SIP application server and performance of the instructions at the second SIP application server in relation to the SIP application session. | 06-30-2011 |
Anat Frydman-Marom, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20110200692 | USE OF A CINNAMON BARK EXTRACT FOR TREATING AMYLOID-ASSOCIATED DISEASES - The present application disclosed the use of a cinnamon extract in the treatment of amyloid-associated diseases and disorders, such as Alzheimer's disease. | 08-18-2011 |
20130225512 | DIPEPTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH AMYLOID FIBRIL FORMATION - Dipeptide analogs comprising a tryptophan (Trp) moiety coupled to a beta-sheet breaker moiety derived from alpha-aminoisobutyric acid (Aib) are disclosed. The dipeptide analogs exhibit an improved performance in inhibiting amyloid fibril formation, as compared to previously described dipeptides. Compositions containing the dipeptide analogs and uses thereof in treating amyloid-associated diseases and disorders are also disclosed. | 08-29-2013 |
20150322110 | DIPEPTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH AMYLOID FIBRIL FORMATION - Dipeptide analogs comprising a tryptophan (Trp) moiety coupled to a beta-sheet breaker moiety derived from alpha-aminoisobutyric acid (Aib) are disclosed. The dipeptide analogs exhibit an improved performance in inhibiting amyloid fibril formation, as compared to previously described dipeptides. Compositions containing the dipetide analogs and uses thereof in treating amyloid-associated diseases and disorders are also disclosed. | 11-12-2015 |
Anat Hashavit, Haifa IL
Patent application number | Description | Published |
---|---|---|
20150261649 | METHOD FOR PERFORMANCE MONITORING AND OPTIMIZATION VIA TREND DETECTION AND FORECASTING - A method for identifying trends in system faults. During a generating stage, monitoring via a software based performance monitoring unit, a state of a server on a network and generating hardware or software performance information which indicate system faults of the server. During an analysis stage including, creating a dataset from the hardware or software performance information and isolating events from the dataset and categorizing each of the isolated events into a type, each type representing one application program call return. For each event in the dataset, assigning a trend score which decays with time such that recent events receive greater weight in the assigning than less recent events. Finally, performing one or more of: outputting a notification of the trend score, utilizing an optimization unit or triggering operation of a fault system handler for the event, when the trend score is above a threshold. | 09-17-2015 |
20160063071 | SCALABLE TREND DETECTION IN A PERSONALIZED SEARCH CONTEXT - A computer implemented method, a computerized system and a computer program product for detecting scalable trends in a personalized search context. The computer implemented method comprising obtaining search results matching a search query, wherein the search query is a query defined by a user, wherein the search results comprise occurrences of events, wherein each occurrence is associated with a timestamp. The method further comprises calculating, by a processor, in response to obtaining the search results, trend scores for the events based on the occurrences comprised by the search results. The method further comprises providing an output to the user based on the trend scores. | 03-03-2016 |
Anat Jatwes, Boca Raton, FL US
Patent application number | Description | Published |
---|---|---|
20140014539 | System and Method for Providing Removable Eraseable Writing Surface - The present invention is a system for utilizing a base article with a removable erasable writing surface, said system comprising a base article, a mechanism constructed and arranged for securing a dry erase board to said base article, a dry erase board constructed and arranged to be removably attached to said base article utilizing said attaching mechanism, wherein said system provides an erasable surface. | 01-16-2014 |
Anat Kaphan, Halonim IL
Patent application number | Description | Published |
---|---|---|
20080234787 | Laser treatment procedure atlas - A user interface for a general purpose laser treatment system is provided. Generally, the user interface may be associated with a carbon dioxide (CO2) laser for use in various surgical procedures, for example, veterinary or medical surgical procedures. A treatment atlas including a collection of treatment procedures is stored within a database structure. The treatment procedures includes laser settings associated with each of the treatment procedures. The interface can provide a recommended treatment procedures to a user based on required application. The treatment atlas can be accessed through the internet and requested treatment procedures (and the corresponding laser settings) can be downloaded to a laser treatment system. The treatment atlas can also be a component of a Web 2.0 social networking system to enable users and system administrators to update and modify the collection of treatment procedures. | 09-25-2008 |
Anat Kerem-Angel, Tel-Aviv IL
Patent application number | Description | Published |
---|---|---|
20110092892 | Body passage cleansing device - The present invention provides a body passage cleansing device suitable for being passed through an internal channel of an endoscope, comprising a distal plug having a proximal end and a distal end, wherein said plug comprises channels, apertures and/or nozzles which are capable of allowing the passage of a fluid therethrough from said proximal end to said distal end, wherein said plug is connected to the distal end of a wire or other actuating means; wherein at least an outer portion of said distal plug is capable of being elastically deformed such that the external diameter and/or outline thereof may be reduced in response to inwardly-directed compression forces exerted thereon; and wherein said channels, apertures and/or nozzles are in a closed conformation when said distal plug is subject to said compression forces, and in an open conformation when said plug is not subject to said compression forces. | 04-21-2011 |
Anat Lavi-Itzkovitz, Ramat-Gan IL
Anat Levi Segal, Shelomi IL
Patent application number | Description | Published |
---|---|---|
20090144320 | METHOD FOR GENERATING AND USING A REUSABLE CUSTOM-DEFINED NESTABLE COMPOUND DATA TYPE AS DATABASE QUALIFIERS - A method for generating and using a reusable custom-defined nestable compound data type for use as a database qualifier provides significant advantages over using traditional non-reusable structured tables of RDBM systems is described. The method and data structures of the invention may be used to define and instantiate flexible nested-record structures that reverse and better expose the relationship between parent records and private child sub-records in a database schema to provide improved referential integrity and visibility into database structure. | 06-04-2009 |
20100131565 | Method for creating a self-configuring database system using a reusable custom-defined nestable compound data type - A method for creating a self-configuring database system using a reusable custom-defined nestable compound data type of the invention provides significant advantages over using traditional non-reusable structured tables of RDBM systems. A data structure concept and associated method support creating a self-configuring database system programmatically responsive to importing data using schema descriptions in multiple formats. Thus, the method and data structures of the invention may be used to define and instantiate flexible nested record structures that reverses and better exposes the relationship between parent records and private child sub-records in a database schema. | 05-27-2010 |
Anat Litan Sever, Kiryat Ono IL
Patent application number | Description | Published |
---|---|---|
20140359465 | Method and Apparatus for Annotated Electronic File Sharing - A method and apparatus for sharing electronic documents and sharing annotations to the same is disclosed. In some aspects, the present teachings include easy to use and flexible user interface elements to assist users in accessing shared files and folders as well as indications to alert the users to updates in the condition of a shared item. The user interface also permits simple but effective sharing of comments relating to content and allows for intuitive social networking features in the context of electronic content sharing. In other aspects, an indicator of how many new unread comments are associated with a shared electronic file exist is placed visually on or beside the actual icon of the share electronic file associated with the comments. | 12-04-2014 |
20150026616 | Method and Apparatus for Simple Presentation and Manipulation of Stored Content - A method and apparatus for manipulating and moving stored electronic content in a device. A display and a user interface are provided that allow a user of a simple and limited resource (e.g., mobile) device to interact with breadcrumb graphical representations of stored information objects (e.g., files, folders) and to move a selected object from one level to another in a multi-level hierarchy of stored information objects in a single active application window. In some aspects, a touch-sensitive display is provided that allows the user to move an object from one location to another with a single (e.g., drag) gesture, even moving the selected object up and down through a directory structure without the need for multiple windows to be presented to the user to do so. | 01-22-2015 |
Anat Marchelli, Migdal Haemek IL
Patent application number | Description | Published |
---|---|---|
20080286885 | METHODS AND SYSTEMS FOR CREATING OR PERFORMING A DYNAMIC SAMPLING SCHEME FOR A PROCESS DURING WHICH MEASUREMENTS ARE PERFORMED ON WAFERS - Various methods and systems for creating or performing a dynamic sampling scheme for a process during which measurements are performed on wafers are provided. One method for creating a dynamic sampling scheme for a process during which measurements are performed on wafers includes performing the measurements on all of the wafers in at least one lot at all measurement spots on the wafers. The method also includes determining an optimal sampling scheme, an enhanced sampling scheme, a reduced sampling scheme, and thresholds for the dynamic sampling scheme for the process based on results of the measurements. The thresholds correspond to values of the measurements at which the optimal sampling scheme, the enhanced sampling scheme, and the reduced sampling scheme are to be used for the process. | 11-20-2008 |
20120208301 | Methods and Systems for Creating or Performing a Dynamic Sampling Scheme for a Process During Which Measurements Are Performed on Wafers - Various methods and systems for creating or performing a dynamic sampling scheme for a process during which measurements are performed on wafers are provided. One method for creating a dynamic sampling scheme for a process during which measurements are performed on wafers includes performing the measurements on all of the wafers in at least one tot at all measurement spots on the wafers. The method also includes determining an optimal sampling scheme, an enhanced sampling scheme, a reduced sampling scheme, and thresholds for the dynamic sampling scheme for the process based on results of the measurements. The thresholds correspond to values of the measurements at which the optimal sampling scheme, the enhanced sampling scheme, and the reduced sampling scheme are to be used for the process. | 08-16-2012 |
Anat Mirelman, Ramat-Gan IL
Patent application number | Description | Published |
---|---|---|
20120109025 | MULTIPLE DEGREE OF FREEDOM REHABILITATION SYSTEM HAVING A SMART FLUID-BASED, MULTI-MODE ACTUATOR - A rehabilitation system that combines robotics and interactive gaming to facilitate performance of task-specific, repetitive, upper extremity/hand motor tasks, to enable individuals undergoing rehabilitation to improve the performance of coordinated movements of the forearm and hand is disclosed. More specifically, the rehabilitation system includes a two degree-of-freedom (DOF) robotic, upper limb rehabilitation system and interactive gaming hardware that is coupled to a computer, to provide a virtual reality-like environment. | 05-03-2012 |
20140276130 | VIRTUAL REALITY FOR MOVEMENT DISORDER DIAGNOSIS AND/OR TREATMENT - Methods and/or systems for diagnosing, monitoring and/or treating persons at risk for falling and/or other pathological conditions. In an exemplary embodiment of the invention, people are diagnosed before they actually start falling. Optionally, the diagnosis includes trying out and identifying one or more fall triggers using virtual reality tools. Optionally or alternatively, treatment includes training the persons using situations and/or triggers which are determined to be relevant for that person. | 09-18-2014 |
20140303508 | FREEZING OF GAIT (FOG), DETECTION, PREDICTION AND/OR TREATMENT - A method and system for provoking gait disorders, such as freezing of gait; usable, for example, for diagnosing and/or treatment thereof. In an exemplary embodiment of the invention, displays of situations calculated to cause freezing of gait are presented to a subject, optionally using virtual reality displays. Optionally or alternatively, incipit freezing of gait is identified using changes in gait parameters, and optionally used to guide attempts at causing freezing of gait. Optionally or alternatively, a portable device is provided which detects incipit freezing of gait and generates a corrective signal to the subject. | 10-09-2014 |
Anat Ohali, Ramat Gan IL
Anat Perets, Wynnewood, PA US
Patent application number | Description | Published |
---|---|---|
20130018454 | Small Diameter Vascular Graft Produced by a Hybrid Method - The present invention relates to a hybrid graft and methods of generating the hybrid graft. The hybrid graft comprises an exterior surface and a luminal surface. The luminal surface comprises a micropattern of grooves to which cells adhere and orient along. The exterior surface comprises electrospun microfibers wherein the microfibers provide mechanical properties to the graft. The hybrid graft is capable supporting endothelial cell attachment, endothelial cell alignment, cell proliferation, and maintaining their in vivo function. The graft of the invention can recapitulate the in vivo morphology and function of natural vascular endothelium. | 01-17-2013 |
Anat Perets, Narbeth, PA US
Patent application number | Description | Published |
---|---|---|
20080213389 | Three-Dimensional Scaffolds for Tissue Engineering Made by Processing Complex Extracts of Natural Extracellular Matrices - Methods of making a biologically active three-dimensional scaffold capable of supporting growth and differentiation of a cell are described. Biologically active three-dimensional scaffold made by the methods of the invention and an engineered tissue made from the scaffolds are described. Fibers of desired porosity can be obtained from non-structural ECM by lyophilization and/or electrospinning which can be useful for numerous tissue engineering applications requiring complex scaffolds, such as wound healing, artificial skin (burns), soft tissue replacement/repair and spinal cord injury. | 09-04-2008 |
Anat Perets, Narberth, PA US
Patent application number | Description | Published |
---|---|---|
20150079143 | THREE-DIMENSIONAL SCAFFOLDS FOR TISSUE ENGINEERING MADE BY PROCESSING COMPLEX EXTRACTS OF NATURAL EXTRACELLULAR MATRICES - Methods of making a biologically active three-dimensional scaffold capable of supporting growth and differentiation of a cell are described. Biologically active three-dimensional scaffold made by the methods of the invention and an engineered tissue made from the scaffolds are described. Fibers of desired porosity can be obtained from non-structural ECM by lyophilization and/or electrospinning which can be useful for numerous tissue engineering applications requiring complex scaffolds, such as wound healing, artificial skin (burns), soft tissue replacement/repair and spinal cord injury. | 03-19-2015 |
20150359619 | Small Diameter Vascular Graft Produced by a Hybrid Method - The present invention relates to a hybrid graft and methods of generating the hybrid graft. The hybrid graft comprises an exterior surface and a luminal surface. The luminal surface comprises a micropattern of grooves to which cells adhere and orient along. The exterior surface comprises electrospun microfibers wherein the microfibers provide mechanical properties to the graft. The hybrid graft is capable supporting endothelial cell attachment, endothelial cell alignment, cell proliferation, and maintaining their in vivo function. The graft of the invention can recapitulate the in vivo morphology and function of natural vascular endothelium. | 12-17-2015 |
Anat Shiloach, Trumbull, CT US
Patent application number | Description | Published |
---|---|---|
20110118162 | LIQUID PERSONAL CLEANSING COMPOSITION - A mild, substantially isotropic skin cleansing solution was found to be able to suspend insoluble components and provide copious amounts of lather. The cleanser is formulated with synthetic anionic surfactants and a specific ratio of carboxylic acid(s) to hydrophobically modified cross-linked acrylate copolymer(s). The carboxylic acid and acrylate polymer combination were found to provide a synergistic effect on zero shear viscosity at 25 C in a specific pH and copolymer/acid concentration ratio range. | 05-19-2011 |
20140162979 | CONCENTRATED LAMELLAR LIQUID PERSONAL CLEANSING COMPOSITION - The invention relates to concentrated liquid cleansing compositions in lamellar phase which possess a lotion-like appearance conveying signals of enhanced moisturization. The use of a specific ratio of synthetic anionic surfactant(s) and co-surfactant(s) to fatty acid(s) in a structured liquid product was found to improve lather production by moderating or eliminating the increase in viscosity upon dilution. In a further embodiment, specific small hydrophobic molecules were found to improve freeze/thaw stability and thereby cause the inventive composition to maintain noticeable moisturization signals. | 06-12-2014 |
20160053206 | LIQUID SOAP HAVING ENHANCED ANTIBACTERIAL ACTIVITY - Method of cleansing human skin employing an aqueous soap composition comprising of fatty acid soap, at least one silver (I) compound having a silver ion solubility (in water at 25° C.) of at least 1×10 | 02-25-2016 |
20160053207 | SOAP BAR HAVING ENHANCED ANTIBACTERIAL ACTIVITY - A soap bar comprising: (a) 25 to 85% by weight, based on the total weight of the bar, of fatty acid soap; (b) 0.1 to 100 ppm by weight, based on the total weight of the bar, of at least one silver (I) compound having a selected silver ion solubility, wherein at 25° C., a 1 wt % solution of the bar in water has a pH of from 9 to 11. | 02-25-2016 |
Anat Shirvan, Herzliya IL
Patent application number | Description | Published |
---|---|---|
20080279774 | Perturbed Membrane-Binding Compounds And Methods Of Using The Same - The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention further provides methods for utilizing said compounds in medical practice, for diagnostic and therapeutic purposes. | 11-13-2008 |
20100035296 | COMPOUNDS AND METHODS FOR DETECTION OF CELLS - The invention relates to compounds comprising an ester group for the detection in vivo of cells undergoing cell death (“dying cells”) such as, for example, cells undergoing apoptosis. These compounds are selectively retained in dying cells relative to normal cells. Thus, the compounds may be used in the detection, diagnosis and treatment of clinical conditions manifested by a cell death process. | 02-11-2010 |
20110257434 | PERTURBED MEMBRANE-BINDING COMPOUNDS AND METHODS OF USING THE SAME - The invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, i.e., cells undergoing cell death, apoptotic cells or activated platelets. The invention further provides methods for utilizing the compounds in medical practice, for diagnostic and therapeutic purposes. | 10-20-2011 |
20120142722 | CONJUGATES OF CYTOTOXIC DRUGS - Novel compounds and pharmaceutical compositions are provided. In one aspect of the invention the compounds may be utilized in medical practice, for example, in treatment of cancer and immune disorders. In another aspect of the invention there is provided a conjugate, comprising a cytotoxic agent and a modulating moiety, the modulating moiety serving to target apoptotic cells. | 06-07-2012 |
20140336359 | SYNTHETIC PEPTIDES FOR TREATMENT OF BACTERIAL INFECTIONS - Disclosed are peptides and methods for the treatment of bacterial infections and associated inflammation. Effective doses and treatment protocols are disclosed. | 11-13-2014 |
Anat Sneh, Boulder, CO US
Patent application number | Description | Published |
---|---|---|
20110310526 | CAPACITORS WITH HIGH ENERGY STORAGE DENSITY AND LOW ESR - Electrostatic capacitors with high capacitance density and high-energy storage are implemented over conventional electrolytic capacitor anode substrates using highly conformal contact layers deposited by atomic layer deposition. Capacitor films that are suitable for energy storage, electrical and electronics circuits, and for integration onto PC boards endure long lifetime and high-temperature operation range. | 12-22-2011 |
Anat Sofer-Raz, Herot IL
Patent application number | Description | Published |
---|---|---|
20090088424 | METHODS AND COMPOSITIONS FOR CONTROLLING THE BIOAVAILABILITY OF POORLY SOLUBLE DRUGS - Provided are methods and compositions for controlling the bioavailability of poorly soluble drugs, including, for example, efravirenz. | 04-02-2009 |
Anat Thieberger Ben-Haim, Kiryat Tivon IL
Patent application number | Description | Published |
---|---|---|
20100159426 | LANGUAGE SKILLS FOR INFANTS - Methods and devices for stimulating the development of phonetic categories by an infant. The device includes a memory element operative to store auditory pieces comprising isolated phonemes in a voice similar to the voice of the infant's parent. The method includes the steps of recording the infant's parent pronouncing isolated phonemes, and playing to the infant auditory pieces comprising isolated phonemes based on the recordings of the infant's parent. | 06-24-2010 |
20120290514 | Methods for predicting affective response from stimuli - Creating a machine learning-based affective response predictor to predict a user's emotional state after being exposed to tokens representing stimuli that influence the user's affective state, comprising: receiving samples comprising temporal windows of token instances to which the user was exposed; the token instances are spread over a long period of time, and a subset of the token instances originate from same source and have overlapping instantiation periods; receiving target values, which represent affective response annotations of the user and correspond to the temporal windows of token instances; and creating the machine learning-based affective response predictor for the user, which compensates for non-linear effects resulting from the user being exposed to the subset of token instances originating from the same source and having overlapping instantiation periods, by running a machine learning training procedure on input data comprising the samples and the corresponding target values. | 11-15-2012 |
20120290515 | Affective response predictor trained on partial data - Creating a machine learning-based affective response predictor of a user when there are significantly more samples than target values available for training, comprising: receiving samples comprising temporal windows of token instances to which the user was exposed; the token instances are spread over a long period of time; receiving intermittent target values corresponding to a subset of the temporal windows of token instances; the target values represent affective response annotations of the user; creating the machine learning-based affective response predictor of the user, by running a semi-supervised machine learning training procedure on the samples and the intermittent corresponding target values; wherein the machine learning-based affective response predictor is more accurate than a predictor created when training only on the samples that have corresponding target values, since it is capable of learning additional information from the samples comprising temporal windows of token instances without corresponding target values. | 11-15-2012 |
20120290517 | Predictor of affective response baseline values - Calculating a situation-dependent baseline value for a user response to token instances representing stimuli that influence the user's affective state, utilizing large time windows and rapid adjustments to changing situations, including: accessing a database storing annotations representing the user's response to token instances originating from multiple distinct token sources; calculating a first situation-dependent baseline value by weighting annotations retrieved from the database and associated with a first situation identifier, which are spread over a long period of time ‘T’; calculating a second situation-dependent baseline value by weighting annotations retrieved from the database and associated with a second situation identifier; wherein the difference between the first and second situation-dependent baseline values is significant, and the method rapidly adjusts to the situation change by exhibiting an extremely shorter transient time between the first and the second situation-dependent baselines than T/2 | 11-15-2012 |
20120290520 | Affective response predictor for a stream of stimuli - Predicting a user's response to a stream of token instances, including: receiving a stream of token instances; partitioning the stream of token instances into consecutive temporal windows of token instances; predicting response of the user to temporal windows of token instances; predicting response of the user to a certain temporal window of token instances; and forwarding the prediction of the user to the stream of token instances. | 11-15-2012 |
20120290521 | Discovering and classifying situations that influence affective response - Methods for detecting and validating an estimated situation using a situation-dependent predictor of a user response to token instances, including: receiving a temporal window of token instances and a putative situation for a user; predicting an expected response of the user to being exposed to the temporal window of token instances; receiving a value of a measurement channel of the user taken during exposure of the user to the temporal window of token instances; identifying that difference between the received value of the user measurement channel and the predicted expected response of the user is above a predefined threshold; and indicating that the putative situation is wrong. | 11-15-2012 |
20160078369 | Methods for training emotional response predictors utilizing attention in visual objects - Described herein are methods for training a predictor of a user's emotional response to stimuli (e.g., digital content). In order to more accurately learn the nature of the emotional response of the user to the stimuli, in some embodiments, the training of the predictor involves collection of attention level data that indicates to which objects the user paid attention. The attention level data may be utilized to weight token instances representing visual objects from the stimuli. Such a weighting can help to train the emotional response predictor to better determine which objects influence the user's affective response and/or the extent of their influence on the user's affective response. In different embodiments, attention level information may come from different sources, such as eye tracking data of the user, and a model for predicting an interest level of the user in various visual objects. | 03-17-2016 |
Anat Thieberger Ben-Haom, Kiryat Tivon IL
Patent application number | Description | Published |
---|---|---|
20090226861 | Language skill development according to infant development - Methods and devices for stimulating an infant to develop additional phonetic categories, including: estimating the infant's development; and selecting an auditory piece appropriate to the estimated development. Wherein the auditory piece comprises isolated phonemes in the infant's parent's voice. | 09-10-2009 |
Anat Zvi, Gedera IL
Patent application number | Description | Published |
---|---|---|
20090136534 | NOVEL RECOMBINANT BCG TUBERCULOSIS VACCINE DESIGNED TO ELICIT IMMUNE RESPONSES TO MYCOBACTERIUM TUBERCULOSIS IN ALL PHYSIOLOGICAL STAGES OF INFECTION AND DISEASE - A vaccine against | 05-28-2009 |
20110117133 | Novel Recombinant BCG Tuberculosis Vaccine Designed to Elicit Immune Responses to Mycobacterium Tuberculosis in all Physiological Stages of Infection and Disease - A vaccine against | 05-19-2011 |
20110206714 | MALARIA VACCINE COMPOSITIONS AND CONSTITUENTS WHICH ELICIT CELL MEDIATED IMMUNITY - Malaria vaccines based on polyepitope constructs that elicit cell-mediated immunity against a broad spectrum of malaria parasites and which cover the majority of HLA alleles are provided. Epitopes in the polyepitope constructs are from regions of the | 08-25-2011 |